CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation

Thomas Edmund Kimber, YiZhong Zhuang, Philip Douglas Thompson

JMD. 2019;12(3):192-194. Published online 2019 September 30 DOI: https://doi.org/10.14802/jmd.19022

Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation

Thomas Edmund Kimber, YiZhong Zhuang, Philip Douglas Thompson

Journal of Movement Disorders. 2019;12(3):192-194

Link1

Link2 Link3

Comparison Between Levodopa-Carbidopa Intestinal Gel Infusion and Subthalamic Nucleus Deep-Brain Stimulation for Advanced Parkinson's Disease: A Systematic Review and Meta-Analysis

Xiao Dong Liu, Yi Bao, Guang jian Liu

Frontiers in Neurology. 2019;10:

Link1

Intestinal Levodopa/Carbidopa Infusion as a Therapeutic Option for Unresponsive Freezing of Gait after Deep Brain Stimulation in Parkinson’s Disease

Belén González-Herrero, Serge Jauma-Classen, Roser Gómez-Llopico, Gerard Plans, Matilde Calopa

Parkinson's Disease. 2020;2020:1-5

Link1

Link2 Link3

Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson’s disease

D. Nyholm, K. Klangemo, A. Johansson

European Journal of Neurology. 2012;19(8):1079-1085

Link1

Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study

Marina Senek, Elisabet I. Nielsen, Dag Nyholm

Movement Disorders. 2016;32(2):283-286

Link1 Link2

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

Dag Nyholm, Per Odin, Anders Johansson, Krai Chatamra, Charles Locke, Sandeep Dutta, Ahmed A. Othman

The AAPS Journal. 2012;15(2):316-323

Link1

Link2 Link3

Levodopa/Carbidopa Intestinal Gel in Parkinson’s Disease

Jiro Fukae, Nobutaka Hattori

NeuroPsychopharmacotherapy. 2020;1-8

Link1

Rescue levodopa‐carbidopa intestinal gel (LCIG) therapy in Parkinson’s disease patients with suboptimal response to deep brain stimulation

Ahmad Elkouzi, Adolfo Ramirez‐Zamora, Pam Zeilman, Matthew Barabas, Robert S. Eisinger, Irene A. Malaty, Michael S. Okun, Leonardo Almeida

Annals of Clinical and Translational Neurology. 2019;6(10):1989-1995

Link1 Link2 Link3 Link4

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa

Ahmed A. Othman, Matthew Rosebraugh, Krai Chatamra, Charles Locke, Sandeep Dutta

Journal of Parkinson's Disease. 2017;7(2):275-278

Link1

Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study

Harmen Moes, Jerney Groenendal-Laurensse, Martje Drent, Gerrit Tissingh, Teus van Laar

Journal of Parkinson's Disease. 2020;1-10

Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. JMD has participated in CrossRef Text and Data Mining service since October 29, 2014.